Chronicle Journal: Finance

Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
S&P Biotech SPDR (NY: XBI)
116.10 USD  -0.67 (-0.57%)
Official Closing Price  /  Updated: 8:00 PM EDT, Jul 9, 2020  /  Add to My Watchlist      
View: Quote News
Fund Overview
S&P Biotech SPDR
Sector
Exchange Traded NY
Net Assets 6.28B
Inception Date
Related Funds
Quote
Price 116.10
Volume 3,510,300
Last Trade Jul 09, 8:00pm
Change (%)
-0.67 (-0.57%)
Prev. Close 116.77
YTD %
+22.62%
Dividend Yield 0.19%
Performance
YTD
+21.42 (22.62%)
1 Month
+11.47 (10.96%)
3 Month
+32.67 (39.16%)
6 Month
+20.28 (21.16%)
1 Year
+28.96 (33.23%)
Chart
Charting
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
The Daily Biotech Pulse: FDA Nod For Osmotica, OptiNose Strikes Co-promotion Deal, Orphan Drug Designation For AnaptysBio
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... Read More
from Benzinga
Prosperity as Far as the Chartology Can See: Secular Bull Market
Long term secular bull markets just don’t begin and end for no good reason. There has to be a catalyst that drives the markets higher over a long period of time. Read More
from Blogs - TalkMarkets
Top News
More News
XBI, INO, NVTA, NVAX: ETF Inflow Alert
Symbols mentioned in this story: XBI, INO, NVTA, NVAX Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... Read More
from ETF Channel
The Daily Biotech Pulse: Intersect ENT Jumps On M&A Speculation, VIVUS Files For Bankruptcy
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... Read More
from Benzinga
Biotech ETFs Rally as ‘Operation Warp Speed’ Fuels Covid-19 Research
Biotechnology sector-related exchange traded funds were among the best performers Tuesday as the government program “Operation Warp Speed” allocates billions of dollars for a quick development and... Read More
from ETF Trends
Tuesday's ETF Movers: XBI, KBWB
In trading on Tuesday, the SPDR— S&P— Biotech ETF is outperforming other ETFs, up about 3% on the day. Components of that ETF showing particular strength include shares of Novavax, up about 29.3% and... Read More
from ETF Channel
The Daily Biotech Pulse: Novavax Lands $1.6B For COVID-19 Vaccine, Amgen Prevails In Avastin Biosimilar Lawsuit, Cellectis Study Placed On Clinical Hold
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... Read More
from Benzinga
SPDR Biotech ETF: A Quality Long-Term Bet
I am bullish on SPDR Biotech ETF and consider it as a long-term pick because it is focused on biotech growth stocks. The biotechnology sector has a lot of potential going forward, especially in the... Read More
from Blogs - TalkMarkets
The Week Ahead In Biotech: Endo, Eagle Pharma FDA Decisions, ObsEva Late-Stage Readouts In Focus
Biotech stocks rebounded in the holiday-shortened week ending July 2as investors reacted to pending clinical trial readouts and ... Read More
from Benzinga
Biotech ETFs To Gain As Coronavirus Vaccine Hopes Strengthen
The race to introduce vaccine and treatment for coronavirus is opening up opportunities, making the biotech sector a prospective space for investments. Therefore, we discuss a few ETFs that provide... Read More
from Blogs - TalkMarkets
Peek Under The Hood: XBI Has 36% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... Read More
from ETF Channel
The Daily Biotech Pulse: Novartis Settles Lawsuit For $678M, Sarepta In-Licenses Gene Therapy Pre-Treatment, Unity Biotech Outlines Second-Half Catalysts
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... Read More
from Benzinga
Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates
The busy calendar of June proved positive for drug approvals, with most scheduled events producing positive outcomes. New molecular ... Read More
from Benzinga
The Daily Biotech Pulse: T2 Biosystems Launches COVID-19 Test, Akero Aces Midstage NASH Study, Aravive Added to Russell Indexes
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... Read More
from Benzinga
The Daily Biotech Pulse: Verrica Flags Potential Regulatory Delay, Back-To-Back FDA Approvals For Merck's Keytruda, OncoCyte Stalls Lung Nodule Malignancy Test
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks ... Read More
from Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Chronicle Journal, Thunder Bay, ON. Powered by BLOX Content Management System from TownNews.com. [Terms of Use | Privacy Policy]